Agilon Health
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Agilon Health, Inc. provides healthcare solutions specifically designed for older adults, delivered through local primary care physicians throughout the United States. As of December 31, 2021, the com...
Latest News
12 hours ago · zacks.com
Agilon Health (AGL) Is Up 2.00% in One Week: What You Should KnowDoes Agilon Health (AGL) have what it takes to be a top stock pick for momentum investors? Let's find out.
14 hours ago · zacks.com
Best Momentum Stocks to Buy for November 16thAGL, GMRS and PH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on November 16th, 2026.
15 hours ago · zacks.com
Fast-paced Momentum Stock Agilon (AGL) Is Still Trading at a BargainAgilon (AGL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
18 hours ago · zacks.com
New Strong Buy Stocks for November 16thHMN, GMRS, AGL, CEPU and ECO have been added to the Zacks Rank #1 (Strong Buy) List on November 16th, 2026.
12 days ago · businesswire.com
agilon health to Host Virtual Investor Event “Driving Performance At Scale: The agilon Framework” on November 17, 2026WESTERVILLE, Ohio--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced that it will host a virtual investor event on Tuesday, November 17, 2026, at 2:00 PM ET. The event will feature Dr. Karthik Rao, chief medical officer; Varun Anand, interim chief technology officer; Heidi Hittner, chief business operations officer; and Dr. Jon Copeland, an agilon physician partner from United Physicians. The.
12 days ago · marketbeat.com
Agilon Health Q3 Earnings Call HighlightsAgilon Health NYSE: AGL raised its full-year 2026 outlook after reporting third-quarter results that exceeded its guidance, driven by higher risk-adjustment revenue, clinical program performance and favorable medical cost development in the first half of the year.
12 days ago · zacks.com
Compared to Estimates, Agilon (AGL) Q3 Earnings: A Look at Key MetricsThe headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
12 days ago · zacks.com
Agilon Health (AGL) Q3 Earnings and Revenues Surpass EstimatesAgilon Health (AGL) came out with quarterly earnings of $1.97 per share, beating the Zacks Consensus Estimate of a loss of $2.01 per share. This compares to a loss of $6.75 per share a year ago.
12 days ago · seekingalpha.com
agilon health, inc. (AGL) Q3 2026 Earnings Call Transcriptagilon health, inc. (AGL) Q3 2026 Earnings Call Transcript
25 days ago · zacks.com
Are Medical Stocks Lagging Agilon Health (AGL) This Year?Here is how Agilon Health (AGL) and Arcturus Therapeutics (ARCT) have performed compared to their sector so far this year.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove AGL